LANTUS Side Effects

7022055-0 |
on Sep 22, 2010 Male patient from UNITED STATES , 90 years of age, was diagnosed with insulin-requiring type 2 diabetes mellitus and was treated with Lantus (View Usage). . Lantus dosage: Dose:10 Unit(s). During the same period patient was treated with OPTICLICK (View Opticlick Review and Opticlick Label ).

7020902-X | Chloropsia, Hypoglycaemia
Patient was taking Lantus (View Usage). Patient had the following side effects: chloropsia, hypoglycaemia on Sep 21, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 64 years of age, weighting 187.4 lb, was diagnosed with type 2 diabetes mellitus and. Lantus dosage: . During the same period patient was treated with PIOGLITAZONE (View Pioglitazone Review and Pioglitazone Label ), NOVORAPID (18-8-9) (View Novorapid Review and Novorapid Label ).

7020798-6 | Pancreatic Disorder
Adverse event was reported on Sep 24, 2010 by a Female patient taking Lantus (View Usage) (Dosage: ) was diagnosed with type 1 diabetes mellitus, kidney transplant rejection and. Location: BRAZIL , weighting 110.2 lb, After Lantus was administered, patient had the following side effects: pancreatic disorder. During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), MYFORTIC (View Myfortic Review and Myfortic Label ).

7020776-7 | Breast Cancer Metastatic, Metastases To Bone
on Sep 21, 2010 Female patient from UNITED STATES , 76 years of age, was treated with Lantus (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer metastatic, metastases to bone. Lantus dosage: Dose:45 Unit(s).


7020757-3 | Condition Aggravated, Vitrectomy
on Sep 21, 2010 Female patient from UNITED STATES , 72 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Lantus (View Usage). Patient had the following side effects: condition aggravated, vitrectomy. Lantus dosage: Dose:20 Unit(s). During the same period patient was treated with OPTICLICK (View Opticlick Review and Opticlick Label ).

7020737-8 | Cerebrovascular Accident
Patient was taking Lantus (View Usage). After Lantus was administered, patient had the following side effects: cerebrovascular accident on Sep 19, 2010 from UNITED STATES Additional patient health information: Female patient , 60 years of age, . Lantus dosage: Dose:40 Unit(s). During the same period patient was treated with SOLOSTAR (View Solostar Review and Solostar Label ).

7020736-6 | Injection Site Reaction, Intentional Overdose
Adverse event was reported on Sep 20, 2010 by a Male patient taking Lantus (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 18 years of age, Patient experienced the following unwanted or unexpected effects: injection site reaction, intentional overdose.

7020732-9 | Alopecia, Cardiac Failure Congestive, Liver Disorder
on Sep 20, 2010 Female patient from UNITED STATES , 51 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Lantus (View Usage). Patient had the following side effects: alopecia, cardiac failure congestive, liver disorder. Lantus dosage: Dose:45 Unit(s). During the same period patient was treated with SOLOSTAR (View Solostar Review and Solostar Label ). Patient was hospitalized.

7020717-2 | Blood Creatine Phosphokinase Increased
on Sep 23, 2010 Male patient from GREECE , 40 years of age, was treated with Lantus (View Usage). After Lantus was administered, patient had the following side effects: blood creatine phosphokinase increased. Lantus dosage: . During the same period patient was treated with APIDRA (6 + 8 + 8 Units) (View Apidra Review and Apidra Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ). Patient was hospitalized.

7018464-6 | Confusional State, Parkinson's Disease
Patient was taking Lantus (View Usage). Patient experienced the following unwanted or unexpected effects: confusional state, parkinson's disease (What is parkinson's disease?) on Sep 17, 2010 from UNITED STATES Additional patient health information: Male patient , 83 years of age, was diagnosed with type 2 diabetes mellitus and. Lantus dosage: Dose:16 Unit(s). During the same period patient was treated with OPTICLICK (View Opticlick Review and Opticlick Label ).

7018462-2 | Blood Glucose Increased, Prostate Cancer Recurrent, Prostatic Specific Antigen Increased
Adverse event was reported on Sep 17, 2010 by a Male patient taking Lantus (View Usage) (Dosage: Sliding Scale) . Location: UNITED STATES , 76 years of age, Patient had the following side effects: blood glucose increased, prostate cancer recurrent, prostatic specific antigen increased. During the same period patient was treated with OPTICLICK (View Opticlick Review and Opticlick Label ).

7018450-6 | Cardiac Pacemaker Insertion
on Sep 20, 2010 Female patient from UNITED STATES , 78 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Lantus (View Usage). After Lantus was administered, patient had the following side effects: cardiac pacemaker insertion. Lantus dosage: Dose:32 Unit(s). During the same period patient was treated with SOLOSTAR (View Solostar Review and Solostar Label ).

7018437-3 | Arthralgia, Cerebral Haemorrhage, Feeling Hot, Meningitis, Pain In Extremity
on Sep 15, 2010 Male patient from UNITED STATES , 60 years of age, was diagnosed with insulin-requiring type 2 diabetes mellitus and was treated with Lantus (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, cerebral haemorrhage, feeling hot, meningitis (What is meningitis?), pain in extremity. Lantus dosage: Dose:92 Unit(s). During the same period patient was treated with SOLOSTAR (View Solostar Review and Solostar Label ), BLOOD THINNER (View Blood Thinner Review and Blood Thinner Label ). Patient was hospitalized.

7018436-1 | Cataract, Intervertebral Disc Operation
Patient was taking Lantus (View Usage). Patient had the following side effects: cataract (What is cataract?), intervertebral disc operation on Sep 21, 2010 from UNITED STATES Additional patient health information: Female patient , 74 years of age, weighting 200.0 lb, was diagnosed with type 2 diabetes mellitus and. Lantus dosage: 25 U In Am22 U Hs. During the same period patient was treated with OPTICLICK (View Opticlick Review and Opticlick Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ). Patient was hospitalized.

7018430-0 | Blood Glucose Increased, Hyperhidrosis, Photosensitivity Reaction, Retinal Haemorrhage, Vision Blurred
Adverse event was reported on Sep 20, 2010 by a Male patient taking Lantus (View Usage) (Dosage: 8 Am And 11 Pm Dose:50 Unit(s)) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , 62 years of age, weighting 235.9 lb, After Lantus was administered, patient had the following side effects: blood glucose increased, hyperhidrosis, photosensitivity reaction, retinal haemorrhage, vision blurred. During the same period patient was treated with HUMALOG (8 Am, 2 Pm, 8 Pm) (View Humalog Review and Humalog Label ).

7018420-8 | Dialysis
on Sep 17, 2010 Male patient from UNITED STATES , 73 years of age, weighting 200.6 lb, was diagnosed with type 2 diabetes mellitus and was treated with Lantus (View Usage). Patient experienced the following unwanted or unexpected effects: dialysis (What is dialysis?). Lantus dosage: Dose:30 Unit(s). During the same period patient was treated with OPTICLICK (View Opticlick Review and Opticlick Label ).

7015660-9 | Adenocarcinoma Pancreas, Bile Duct Obstruction, Biliary Dilatation, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Pancreatic Duct Obstruction, Pruritus, Transaminases Increased, Urine Colour Abnormal
on Sep 17, 2010 Female patient from UNITED STATES , 80 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Lantus (View Usage). Patient had the following side effects: adenocarcinoma pancreas, bile duct obstruction, biliary dilatation, blood alkaline phosphatase increased, blood bilirubin increased, pancreatic duct obstruction, pruritus, transaminases increased, urine colour abnormal. Lantus dosage: .

7015070-4 | Arthritis, Fall, Fracture, Gait Disturbance
Patient was taking Lantus (View Usage). After Lantus was administered, patient had the following side effects: arthritis (What is arthritis?), fall (What is fall?), fracture (What is fracture?), gait disturbance on Sep 18, 2010 from UNITED STATES Additional patient health information: Female patient , 83 years of age, was diagnosed with type 2 diabetes mellitus and. Lantus dosage: Dose:20 Unit(s). During the same period patient was treated with SOLOSTAR (View Solostar Review and Solostar Label ). Patient was hospitalized.

7015062-5 | Cerebrovascular Accident, Memory Impairment, Speech Disorder
Adverse event was reported on Sep 16, 2010 by a Female patient taking Lantus (View Usage) (Dosage: Dose:20 Unit(s)) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , 59 years of age, Patient experienced the following unwanted or unexpected effects: cerebrovascular accident, memory impairment, speech disorder. During the same period patient was treated with OPTICLICK (View Opticlick Review and Opticlick Label ).

7015060-1 | Cataract, Glaucoma, Joint Injury, Visual Acuity Reduced
on Sep 16, 2010 Female patient from UNITED STATES , 64 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Lantus (View Usage). Patient had the following side effects: cataract (What is cataract?), glaucoma (What is glaucoma?), joint injury, visual acuity reduced. Lantus dosage: Dose:35 Unit(s). During the same period patient was treated with OPTICLICK (View Opticlick Review and Opticlick Label ).

7015045-5 | Cold Sweat, Dizziness, Hyperglycaemia, Hypoglycaemia, Pneumonia
on Sep 16, 2010 Male patient from BRAZIL , 70 years of age, weighting 145.5 lb, was diagnosed with type 1 diabetes mellitus, hypertension and was treated with Lantus (View Usage). After Lantus was administered, patient had the following side effects: cold sweat, dizziness (What is dizziness?), hyperglycaemia, hypoglycaemia, pneumonia (What is pneumonia?). Lantus dosage: . During the same period patient was treated with OPTIPEN (View Optipen Review and Optipen Label ), APIDRA SOLOSTAR (5-10 Iu) (View Apidra Solostar Review and Apidra Solostar Label ), LIPIDIL (View Lipidil Review and Lipidil Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ATENOLOL (View Atenolol Review and Atenolol Label ). Patient was hospitalized.

7015035-2 | Condition Aggravated, Coronary Artery Occlusion, Hypertension
Patient was taking Lantus (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, coronary artery occlusion, hypertension on Sep 16, 2010 from BRAZIL Additional patient health information: Female patient , weighting 154.3 lb, was diagnosed with hypertension, cardiovascular event prophylaxis and. Lantus dosage: 10-12 Iu. During the same period patient was treated with OPTIPEN (View Optipen Review and Optipen Label ), REPAGLINIDE (View Repaglinide Review and Repaglinide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (View Losartan Potassium And Hydrochlorothiazide Review and Losartan Potassium And Hydrochlorothiazide Label ), JANUVIA (View Januvia Review and Januvia Label ), ROSUVASTATIN (View Rosuvastatin Review and Rosuvastatin Label ), PIOGLITAZONE (View Pioglitazone Review and Pioglitazone Label ), SUSTRATE (View Sustrate Review and Sustrate Label ).

7014833-9 | Chronic Obstructive Pulmonary Disease, Hypoglycaemia, Pneumonia
Adverse event was reported on Sep 16, 2010 by a Female patient taking Lantus (View Usage) (Dosage: Dose:70 Unit(s)) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , 75 years of age, Patient had the following side effects: chronic obstructive pulmonary disease, hypoglycaemia, pneumonia (What is pneumonia?). During the same period patient was treated with APIDRA (On A Sliding Scale (she Averaged 50 Units Daily)) (View Apidra Review and Apidra Label ), OPTICLICK (View Opticlick Review and Opticlick Label ), NOVOLOG (View Novolog Review and Novolog Label ). Patient was hospitalized.

7013185-8 |
on Sep 20, 2010 Female patient from UNITED KINGDOM , 26 years of age, weighting 205.3 lb, was treated with Lantus (View Usage). . Lantus dosage: . During the same period patient was treated with NOVORAPID (View Novorapid Review and Novorapid Label ), FLUTICASONE PROPIONATE/SALMETEROL (View Fluticasone Propionate/salmeterol Review and Fluticasone Propionate/salmeterol Label ), SALBUTAMOL (View Salbutamol Review and Salbutamol Label ).

7010494-3 | Asthma, Brain Neoplasm
on Sep 15, 2010 Female patient from UNITED STATES , 66 years of age, was diagnosed with diabetes mellitus and was treated with Lantus (View Usage). Patient experienced the following unwanted or unexpected effects: asthma (What is asthma?), brain neoplasm. Lantus dosage: Dose:56 Unit(s). During the same period patient was treated with SOLOSTAR (View Solostar Review and Solostar Label ).

7009439-1 | Spinal Compression Fracture
Patient was taking Lantus (View Usage). Patient had the following side effects: spinal compression fracture on Sep 15, 2010 from UNITED STATES Additional patient health information: Female patient , 63 years of age, was diagnosed with type 2 diabetes mellitus and. Lantus dosage: 65 To 82 Units Daily. Patient was hospitalized.

7009411-1 | Blood Uric Acid Increased, Dehydration, Gout, Implantable Defibrillator Insertion, Pulmonary Oedema, Weight Decreased
Adverse event was reported on Sep 14, 2010 by a Female patient taking Lantus (View Usage) (Dosage: Dose:10 Unit(s)) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , 54 years of age, weighting 253.5 lb, After Lantus was administered, patient had the following side effects: blood uric acid increased, dehydration, gout (What is gout?), implantable defibrillator insertion, pulmonary oedema, weight decreased. During the same period patient was treated with OPTICLICK (View Opticlick Review and Opticlick Label ). Patient was hospitalized.

7008063-4 | Cataract, Eye Laser Surgery
on Sep 15, 2010 Female patient from UNITED STATES , 73 years of age, weighting 180.8 lb, was diagnosed with type 2 diabetes mellitus and was treated with Lantus (View Usage). Patient experienced the following unwanted or unexpected effects: cataract (What is cataract?), eye laser surgery. Lantus dosage: . During the same period patient was treated with OPTICLICK (View Opticlick Review and Opticlick Label ).

7008033-6 | Cataract, Lung Disorder
on Sep 14, 2010 Male patient from UNITED STATES , 81 years of age, weighting 200.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Lantus (View Usage). Patient had the following side effects: cataract (What is cataract?), lung disorder. Lantus dosage: Dose:24 Unit(s). During the same period patient was treated with OPTICLICK (View Opticlick Review and Opticlick Label ), ADVAIR DISKUS 100/50 (1 Inhalation Twice A Day250/50 Mcg) (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), ALBUTEROL SULFATE (1 Unit Dose Via Nebulized 4 Time A Day As Needed) (View Albuterol Sulfate Review and Albuterol Sulfate Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ). Patient was hospitalized.

7008007-5 | Blood Glucose Increased, Pneumonia, Shock Hypoglycaemic, Tremor, Weight Decreased
Patient was taking Lantus (View Usage). After Lantus was administered, patient had the following side effects: blood glucose increased, pneumonia (What is pneumonia?), shock hypoglycaemic, tremor, weight decreased on Sep 14, 2010 from UNITED STATES Additional patient health information: Male patient , 74 years of age, was diagnosed with type 2 diabetes mellitus and. Lantus dosage: 16-18 Units Daily. During the same period patient was treated with SOLOSTAR (View Solostar Review and Solostar Label ), INSULIN DETEMIR (View Insulin Detemir Review and Insulin Detemir Label ), JANUVIA (View Januvia Review and Januvia Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), PLAVIX (View Plavix Review and Plavix Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

7008001-4 | Hyperglycaemia, Sarcoidosis, Visual Impairment
Adverse event was reported on Sep 15, 2010 by a Female patient taking Lantus (View Usage) (Dosage: Dose:45 Unit(s)) was diagnosed with type 2 diabetes mellitus, hypertension, sarcoidosis and. Location: UNITED STATES , 49 years of age, weighting 182.0 lb, Patient experienced the following unwanted or unexpected effects: hyperglycaemia, sarcoidosis, visual impairment. During the same period patient was treated with SOLOSTAR (View Solostar Review and Solostar Label ), BENICAR (View Benicar Review and Benicar Label ), FOLIC ACID (2 Tablets Daily) (View Folic Acid Review and Folic Acid Label ), METHOTREXATE (8 Tablets Every Weekly) (View Methotrexate Review and Methotrexate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CELEXA (View Celexa Review and Celexa Label ). Patient was hospitalized.

7007976-7 | Blood Sodium Decreased, Decubitus Ulcer, Dehydration, Dysuria
on Sep 15, 2010 Male patient from UNITED STATES , 87 years of age, weighting 136.7 lb, was diagnosed with type 2 diabetes mellitus, gout (What is gout?) and was treated with Lantus (View Usage). Patient had the following side effects: blood sodium decreased, decubitus ulcer, dehydration, dysuria. Lantus dosage: Sliding Scale. During the same period patient was treated with OPTICLICK (View Opticlick Review and Opticlick Label ), AVAPRO (View Avapro Review and Avapro Label ), LASIX (View Lasix Review and Lasix Label ), COLCHICINE (View Colchicine Review and Colchicine Label ), COREG (View Coreg Review and Coreg Label ). Patient was hospitalized.

7007800-2 | Cellulitis, Rash, Swelling
on Sep 15, 2010 Female patient from UNITED STATES , 54 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Lantus (View Usage). After Lantus was administered, patient had the following side effects: cellulitis (What is cellulitis?), rash (What is rash?), swelling. Lantus dosage: Dose:10 Unit(s). Patient was hospitalized.

7005154-9 | Loss Of Consciousness, Rash
Patient was taking Lantus (View Usage). Patient experienced the following unwanted or unexpected effects: loss of consciousness, rash (What is rash?) on Sep 13, 2010 from UNITED STATES Additional patient health information: Female patient , 68 years of age, was diagnosed with type 2 diabetes mellitus and. Lantus dosage: Dose:40 Unit(s). During the same period patient was treated with OPTICLICK (View Opticlick Review and Opticlick Label ). Patient was hospitalized.

7005144-6 | Visual Impairment
Adverse event was reported on Sep 13, 2010 by a Male patient taking Lantus (View Usage) (Dosage: Dose:19 Unit(s)) was diagnosed with diabetes mellitus and. Location: UNITED STATES , 64 years of age, Patient had the following side effects: visual impairment. During the same period patient was treated with SOLOSTAR (Dose:19 Unit(s)) (View Solostar Review and Solostar Label ).

7005105-7 | Glaucoma, Vision Blurred
on Sep 14, 2010 Male patient from UNITED STATES , 64 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Lantus (View Usage). After Lantus was administered, patient had the following side effects: glaucoma (What is glaucoma?), vision blurred. Lantus dosage: Taken Lantus Via Opticlik For Over 3 Years. Dose:40 Unit(s). During the same period patient was treated with OPTICLICK (Had Opticlik For Over 3 Years.) (View Opticlick Review and Opticlick Label ).

7005049-0 | Blood Glucose Increased, Joint Dislocation, Upper Limb Fracture
on Sep 13, 2010 Female patient from BRAZIL , child 9 years of age, weighting 68.34 lb, was diagnosed with type 1 diabetes mellitus and was treated with Lantus (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, joint dislocation, upper limb fracture. Lantus dosage: . During the same period patient was treated with SOLOSTAR (View Solostar Review and Solostar Label ), NOVORAPID (View Novorapid Review and Novorapid Label ). Patient was hospitalized.

7005043-X | Depression, Fall, Feeling Abnormal, Headache, Hyperglycaemia, Hypertension, Loss Of Consciousness, Malaise
Patient was taking Lantus (View Usage). Patient had the following side effects: depression (What is depression?), fall (What is fall?), feeling abnormal, headache (What is headache?), hyperglycaemia, hypertension, loss of consciousness, malaise on Sep 13, 2010 from UNITED STATES Additional patient health information: Female patient , 54 years of age, weighting 180.8 lb, was diagnosed with type 2 diabetes mellitus and. Lantus dosage: Dose:15 Unit(s). During the same period patient was treated with SOLOSTAR (View Solostar Review and Solostar Label ), HUMALOG (View Humalog Review and Humalog Label ). Patient was hospitalized.

7005036-2 | Blood Glucose Increased, Cardiomegaly, Chest Pain, Diarrhoea, Heart Rate Irregular, Peripheral Vascular Disorder
Adverse event was reported on Sep 13, 2010 by a Male patient taking Lantus (View Usage) (Dosage: Dose:75 Unit(s)) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , 59 years of age, After Lantus was administered, patient had the following side effects: blood glucose increased, cardiomegaly, chest pain (What is chest pain?), diarrhoea, heart rate irregular, peripheral vascular disorder. During the same period patient was treated with OPTICLICK (View Opticlick Review and Opticlick Label ), AMARYL (1 Pill Twice Daily) (View Amaryl Review and Amaryl Label ). Patient was hospitalized.

7005026-X | Breast Cancer, Hypertension, Injection Site Pain
on Sep 15, 2010 Female patient from BRAZIL , weighting 149.9 lb, was diagnosed with anxiety (What is anxiety?) and was treated with Lantus (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?), hypertension, injection site pain. Lantus dosage: . During the same period patient was treated with OPTIPEN (View Optipen Review and Optipen Label ), METFORMIN (View Metformin Review and Metformin Label ), GINKGO BILOBA (View Ginkgo Biloba Review and Ginkgo Biloba Label ), CITALOR (View Citalor Review and Citalor Label ), CALCIUM PHOSPHATE (View Calcium Phosphate Review and Calcium Phosphate Label ), CALCIFEROL (View Calciferol Review and Calciferol Label ), BONIVA (View Boniva Review and Boniva Label ), BROMAZEPAM (View Bromazepam Review and Bromazepam Label ).

7001724-2 | Optic Atrophy
on Sep 13, 2010 Female patient from UNITED STATES , 63 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Lantus (View Usage). Patient had the following side effects: optic atrophy. Lantus dosage: Dose:10 Unit(s).

7001710-2 | Diabetic Coma
Patient was taking Lantus (View Usage). After Lantus was administered, patient had the following side effects: diabetic coma on Sep 11, 2010 from UNITED STATES Additional patient health information: Female patient , 54 years of age, . Lantus dosage: 1 To 2 Units. During the same period patient was treated with SOLOSTAR (View Solostar Review and Solostar Label ). Patient was hospitalized.

7001657-1 | Decubitus Ulcer, Fall, Hip Fracture
Adverse event was reported on Sep 11, 2010 by a Male patient taking Lantus (View Usage) (Dosage: Dose:41 Unit(s)) . Location: UNITED STATES , 73 years of age, Patient experienced the following unwanted or unexpected effects: decubitus ulcer, fall (What is fall?), hip fracture. During the same period patient was treated with OPTICLICK (View Opticlick Review and Opticlick Label ). Patient was hospitalized.

7001656-X | Leg Amputation
on Sep 13, 2010 Female patient from UNITED STATES , 88 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Lantus (View Usage). Patient had the following side effects: leg amputation. Lantus dosage: 17-18 Units A Day. During the same period patient was treated with OPTICLICK (View Opticlick Review and Opticlick Label ).

7001584-X | Blood Glucose Increased, Pulmonary Arterial Hypertension
on Sep 10, 2010 Male patient from UNITED STATES , 69 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Lantus (View Usage). After Lantus was administered, patient had the following side effects: blood glucose increased, pulmonary arterial hypertension. Lantus dosage: Dose:30 Unit(s). During the same period patient was treated with SOLOSTAR (View Solostar Review and Solostar Label ).

7001582-6 | Coronary Artery Occlusion, Retinal Disorder, Visual Impairment
Patient was taking Lantus (View Usage). Patient experienced the following unwanted or unexpected effects: coronary artery occlusion, retinal disorder (What is retinal disorder?), visual impairment on Sep 12, 2010 from UNITED STATES Additional patient health information: Male patient , 72 years of age, . Lantus dosage: Dose:30 Unit(s). During the same period patient was treated with OPTICLICK (View Opticlick Review and Opticlick Label ).

7001578-4 | Myocardial Infarction
Adverse event was reported on Sep 09, 2010 by a Female patient taking Lantus (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , 46 years of age, Patient had the following side effects: myocardial infarction. During the same period patient was treated with OPTICLICK (View Opticlick Review and Opticlick Label ).

7000481-3 | Myocardial Infarction
on Sep 08, 2010 Male patient from SOUTH AFRICA , weighting 190.9 lb, was diagnosed with type 2 diabetes mellitus, hypertension and was treated with Lantus (View Usage). After Lantus was administered, patient had the following side effects: myocardial infarction. Lantus dosage: 105 Iu, Qd. During the same period patient was treated with NOVORAPID FLEXPEN (0 Iu, Qd) (View Novorapid Flexpen Review and Novorapid Flexpen Label ), ENALAPRIL (5 Mg, Bid) (View Enalapril Review and Enalapril Label ).

6992664-3 | Hypoglycaemia, Intentional Overdose, Suicide Attempt
on Sep 13, 2010 Male patient from SPAIN , 36 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Lantus (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia, intentional overdose, suicide attempt. Lantus dosage: .

6992655-2 | Cataract, Diabetic Retinopathy, Hip Arthroplasty, Vision Blurred
Patient was taking Lantus (View Usage). Patient had the following side effects: cataract (What is cataract?), diabetic retinopathy, hip arthroplasty, vision blurred on Sep 08, 2010 from UNITED STATES Additional patient health information: Male patient , 76 years of age, . Lantus dosage: Dose:40 Unit(s). During the same period patient was treated with OPTICLICK (View Opticlick Review and Opticlick Label ).